[1]
“Retraction: Monotherapy with meropenem versus combination therapy of ceftazidime plus amikacin for empirical treatment of cancer patients with Febrile Neutropenic (FN): systematic review and meta-analysis”, Eur J Oncol, vol. 20, no. 1, pp. 5–16, Sep. 2015, Accessed: Jul. 18, 2024. [Online]. Available: https://mattioli1885journals.com/index.php/EJOEH/article/view/4122